Not So Different: Kathy Oubre on the Benefits of Using Biosimilars in a Community Oncology Practice

November 15, 2020

Kathy Oubre, MS, chief operating officer at the Pontchartrain Cancer Center in Louisiana, discusses the value of biosimilars.

On October 28, the Community Oncology Alliance (COA) hosted a summit on oncology payment reform which featured a panel entitled “Biosimilar Opportunities, Challenges, and Realities.” Panelist Kathy Oubre, MS, chief operating officer at the Pontchartrain Cancer Center in Louisiana and member of the board of directors for COA, discussed some of the current challenges and barriers to uptake for biosimilars. Excerpts from that panel discussion are included here.

To learn more about the COA's virtual Payer Exchange Summit on Oncology Payment Reform, click here.
To learn more about Pontchartrain Cancer Center, click here.


x